Aldeyra Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aldeyra Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q1 2015 to Q1 2024.
  • Aldeyra Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $60.6K, a 9.47% decline year-over-year.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2024 was $250K, a 5.01% decline from 2023.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2023 was $263K, a 1.57% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2022 was $259K, a 2.07% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $60.6K -$6.34K -9.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q1 2023 $67K +$4.23K +6.74% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $62.7K -$5.12K -7.55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $67.9K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2019 $24.2K +$12.8K +113% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q1 2018 $11.4K +$1.75K +18.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $9.66K +$1.56K +19.2% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q1 2016 $8.1K +$6.85K +547% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $1.25K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.